Building from more than a decade of proven leadership in the wireless connectivity space, Texas Instruments Incorporated (TI) (NASDAQ: TXN) today unveiled the SimpleLink™ product family, the industry’s widest portfolio of easy-to-use wireless connectivity technologies for low-power, low-cost embedded applications. The SimpleLink family includes self-contained wireless processors, aimed at enabling easy integration with any embedded system.
The cornerstone offering in this new family is the new SimpleLink Wi-Fi® CC3000 product: an easy-to-implement Wi-Fi solution that will lead the charge in expanding the world’s Internet of Things. The SimpleLink Wi-Fi CC3000 is a self-contained 802.11 network processor, making it ideal for simple and quick addition of Internet connectivity to any embedded application. For full details on the SimpleLink Wi-Fi CC3000 and all SimpleLink products, visit http://ti.com/simplelink.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54039-texas-instruments-launches-product-family-simplelink-wi-fi-cc3000
LivePerson, Inc. (NASDAQ: LPSN), a provider of real-time chat, voice and content solutions that increase conversions and improve customer experience, today announced several new innovations in online engagement. These new capabilities enhance the intelligence, extend the reach, and improve the efficiency of online chat.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54324-liveperson-lp-chat-latest-innovations-in-online-engagement
E*TRADE Financial Corporation (NASDAQ: ETFC) today announced that E*TRADE Securities LLC has unveiled a new 30-second “Talking Baby” advertisement which will run during the NBC® television network broadcast of Super Bowl XLVI.
The Super Bowl spot, entitled “Fatherhood,” features the E*TRADE Baby reassuring a nervous new dad about planning for his newborn daughter’s future with help from Financial Consultants at E*TRADE.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54519-e-trade-commercial-baby-super-bowl-advertisements-ads
Achieving another wireless connectivity milestone, Texas Instruments Incorporated (TI) (NASDAQ: TXN) today introduced the WiLink™ 8.0 product family: a collection of 45-nanometer single-chip solutions that integrate up to five different radios, and set the stage for next-generation mobile Wi-Fi®, GNSS, NFC, Bluetooth® and FM transmit/receive applications. The WiLink 8.0 architecture supports various combinations of these technologies, allowing for customized solutions to address the unique needs and price points of all mobile markets. Each chip variant comes in a compact WSP package that can be mounted directly on a PCB, and includes all required RF front ends, a complete power management system, and comprehensive coexistence mechanisms. At the system level, the five-radio WiLink 8.0 chip offers a 60 percent cost reduction, 45 percent decrease in size and 30 percent lower power consumption compared to traditional multi-chip offerings. Complete details: www.ti.com/wilink8.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54040-texas-instruments-ti-wilink8-5-in-1-wireless-connectivity-next-gen-mobile
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
Envision a wireless experience with maximum data rates and no dropped calls at cell edges. Envision limited service areas being a thing of the past. Envision lower costs and greener solutions for base stations. Now, envision the technology that makes all of this is possible. Texas Instruments Incorporated (TI) (NASDAQ: TXN) today is unveiling the industry’s most comprehensive wireless infrastructure System-on-Chip (SoC), featuring an ideal mix of processing elements for both ultra-high capacity small cell and macro base stations. TI’s scalable TMS320TCI6636 delivers breakthrough performance, simultaneous 3G and 4G coverage and capacity expansion features that wireless operators and their users will love. For more information please visit www.ti.com/multicore.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54042-texas-instruments-ti-multi-standard-soc-ultra-high-capacity
Whole Foods Market® (NASDAQ: WFM) is launching Dark Rye, an online magazine that explores food, art, health and sustainable living. The site features compelling people and content through storytelling with video, photography, recipes and articles. Dark Rye celebrates the movers and doers of our time and aims to motivate and inspire people to take a bite out of life. Sample Dark Rye at www.darkrye.com.
To view Multimedia News Release, go to http://www.multivu.com/mnr/49712-whole-foods-market-taste-life-with-new-online-magazine-dark-rye
Texas Instruments Incorporated (TI) (NASDAQ: TXN) today introduced TI Silicon Valley Labs, its research center for innovation in analog and mixed signal electronics. The labs’ charter is to conduct advanced research and development in analog and mixed signal circuits and technologies through recruitment of top talent and close collaboration with universities and customers. Watch a video about TI Silicon Valley Labs at http://www.ti.com/analogresearch-prv.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54043-texas-instruments-ti-silicon-valley-labs-analog-mixed-signal-electronics
Today Walgreens (NYSE, NASDAQ: WAG), announced the Walgreens Way to Well Health Tour with AARP, a program dedicated to providing free prevention and early detection health services to some of the nation’s most underserved communities. Now through December 2012, the tour will provide free tests, assessments, education and consulting services to communities located predominantly in cities with the highest prevalence for leading diseases, and highest uninsured and unemployed populations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54970-walgreens-way-to-well-health-tour-with-aarp
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Walgreens (NYSE, NASDAQ: WAG) and the National Urban League (NUL), today announced the launch of the Walgreens Way to Well Health Tour with National Urban League as a charitable component of the Walgreens Way to Well Commitment®. The national tour will provide free health resources to residents in urban and minority communities who experience disproportionately higher rates of preventable disease. The service is free and insurance will not be billed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54971-walgreens-way-to-well-health-tour-with-nul
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
